Loading clinical trials...
Loading clinical trials...
A Randomized Controlled Multi-center Clinical Trial on Treatment of Stage Ⅲ/Ⅳ NK/T Cell Lymphoma With DDGP Regiment (Gemcitabine,Pegaspargase,Cisplatin,Dexamethasone)
Conditions
Interventions
DDGP(cisplatin,dexamethasone,gemcitabine,pegaspargase)
Modified SMILE （MTX，DEX，IFO，L-ASP，Etoposide，Mesna）
Locations
1
China
Oncology Department of The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
Start Date
January 1, 2011
Primary Completion Date
December 1, 2015
Completion Date
May 1, 2019
Last Updated
July 17, 2015
Lead Sponsor
Mingzhi Zhang
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions